Illustrative

Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells

Medical Xpress·Jun 15

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

research suggests that tumor-triggered neutrophils may be a factor in the failure of some immunotherapies. these neutrophils are believed to interfere with cancer-killing t cells, potentially hindering the treatment's effectiveness. the discovery may help explain why some immunotherapies are not successful in certain cases.

Full coverage

Some immune cells can limit the effect of cancer immunotherapy

Karolinska Institutet·Jun 15

Early immune clues that determine who develops TB may lead to new ways to intervene earlier and stop the disease

Medical Xpress·Jun 24

Common asthma drug helps fight hard-to-treat cancers, including aggressive breast cancers, early study finds

Live Science·May 20

Cold and hot tumors: from molecular mechanisms to targeted therapy

Nature·Oct 18

White blood cell “nets” could be early warning sign of major immunotherapy complication

Michigan Medicine·May 31

Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms

Wiley Online Library·Nov 1

Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils

Frontiers·Jul 1

Activated neutrophils: the anti-hero

Nature·Mar 2

View original report at Medical Xpress ↗

Fetching the latest headlines…